Transport of L-arginine and nitric oxide formation in human platelets

被引:21
作者
Signorello, MG [1 ]
Pascale, R [1 ]
Leoncini, G [1 ]
机构
[1] Univ Genoa, Dipartimento Med Sperimentale, Sez Biochim, I-16132 Genoa, Italy
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2003年 / 270卷 / 09期
关键词
L-arginine; nitric oxide; platelets; transport;
D O I
10.1046/j.1432-1033.2003.03572.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The results of the present study show that human platelets take up l-arginine by two transport systems which are compatible with the systems y(+) and y(+) L. These Na+ independent transporters have been distinguished by treating platelets with N -ethylmaleimide that blocks selectively system y(+) . System y(+) , that accounts for 30-40% of the total transport, is characterized by low affinity for l-arginine, is unaffected by l-leucine, is sensitive to changes of membrane potential and to trans -stimulation. The other component of l-arginine transport identified with the system y(+) L (approximately 60-70% of the total flux) shows high affinity for l-arginine, is insensitive to N -ethylmaleimide treatment, unaffected by changes in membrane potential, sensitive to trans -stimulation and inhibited by l-leucine in the presence of Na+ . Moreover a strict correlation between l-arginine transport and nitric oxide (NO) production in whole cells was found. N -ethylmaleimide and l-leucine decreased NO production as well as cGMP elevation, and the effect on NO and cGMP were closely related. It is likely that the l-arginine transport systems y(+) and y(+) L are both involved in supplying substrate for NO production and regulation in human platelets.
引用
收藏
页码:2005 / 2012
页数:8
相关论文
共 44 条
[1]  
BOGER RH, 1995, ATHEROSCLEROSIS, V117, P273, DOI 10.1016/0021-9150(95)05582-H
[2]   L-ARGININE TRANSPORT IS INCREASED IN MACROPHAGES GENERATING NITRIC-OXIDE [J].
BOGLE, RG ;
BAYDOUN, AR ;
PEARSON, JD ;
MONCADA, S ;
MANN, GE .
BIOCHEMICAL JOURNAL, 1992, 284 :15-18
[3]   The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine [J].
Bröer, A ;
Wagner, CA ;
Lang, F ;
Bröer, S .
BIOCHEMICAL JOURNAL, 2000, 349 :787-795
[4]   Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults [J].
Clarkson, P ;
Adams, MR ;
Powe, AJ ;
Donald, AE ;
McCredie, R ;
Robinson, J ;
McCarthy, SN ;
Keech, A ;
Celermajer, DS ;
Deanfield, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) :1989-1994
[5]  
Closs EI, 2000, MOL PHARMACOL, V57, P68
[6]   Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: Three related carriers with distinct transport properties [J].
Closs, EI ;
Graf, P ;
Habermeier, A ;
Cunningham, JM ;
Forstermann, U .
BIOCHEMISTRY, 1997, 36 (21) :6462-6468
[7]   Effect of gabexate mesylate (FOY), a drug for serine proteinase-mediated diseases, on the nitric oxide pathway [J].
Colasanti, M ;
Persichini, T ;
Venturini, G ;
Menegatti, E ;
Lauro, GM ;
Ascenzi, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (02) :453-456
[8]   L-ARGININE IMPROVES ENDOTHELIUM-DEPENDENT VASODILATION IN HYPERCHOLESTEROLEMIC HUMANS [J].
CREAGER, MA ;
GALLAGHER, SJ ;
GIRERD, XJ ;
COLEMAN, SM ;
DZAU, VJ ;
COOKE, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1248-1253
[9]   Arginine transport through system y+L in cultured human fibroblasts:: normal phenotype of cells from LPI subjects [J].
Dall'Asta, V ;
Bussolati, O ;
Sala, R ;
Rotoli, BM ;
Sebastio, G ;
Sperandeo, MP ;
Andria, G ;
Gazzola, GC .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (06) :C1829-C1837
[10]   N-ETHYLMALEIMIDE DISCRIMINATES BETWEEN 2 LYSINE TRANSPORT-SYSTEMS IN HUMAN ERYTHROCYTES [J].
DEVES, R ;
ANGELO, S ;
CHAVEZ, P .
JOURNAL OF PHYSIOLOGY-LONDON, 1993, 468 :753-766